Unwrap.Fund
See how BBP fits your portfolio →
MF · holdings as filed 2026-04-30

What's inside BBP?

Virtus Biotech Etf
Holdings
62
positions in the fund
Top 10
27%
of fund assets
Expense ratio
0.34%
net, per year
Fund size
$59M
total net assets
Top 15 holdings
1
IBRXIMMUNITYBIO INC
4.80%
2
—DREYFUS GOVERNMENT CASH MANAGE
3.15%
3
APLSUSDAPELLIS PHARMACEUTICALS INC
2.59%
4
4XC1KALVISTA PHARMACEUTICALS INC
2.52%
5
MRNAMODERNA INC
2.49%
6
IOVAIOVANCE BIOTHERAPEUTICS INC
2.44%
7
MIRMMIRUM PHARMACEUTICALS INC
2.39%
8
AXSMAXSOME THERAPEUTICS INC
2.24%
9
KNSAKINIKSA PHARMACEUTICALS INTE
2.06%
10
ROIVROIVANT SCIENCES LTD
2.06%
11
ZLABZAI LAB LTD-ADR
1.94%
12
LGNDLIGAND PHARMACEUTICALS
1.93%
13
BCRXBIOCRYST PHARMACEUTICALS INC
1.93%
14
TVTXTRAVERE THERAPEUTICS INC
1.93%
15
NVAXNOVAVAX INC
1.93%
Sectors
1Health Care
93%
2Unclassified
8%
3Industrials
2%
Geography
1United States
87%
2Unclassified
3%
3Germany
3%
4United Kingdom
2%
5Bermuda
2%
6Denmark
2%
7Canada
2%
8Switzerland
1%
Hold BBP alongside other funds? See your combined true holdings, overlap, and blended fees — free, no signup.
Unwrap your portfolio →
Data source: official SEC Form N-PORT filings (as of 2026-04-30); expense ratio from SEC prospectus (risk/return) filings. Fund holdings are disclosed quarterly and may reflect a 60-day reporting delay.
Informational and educational only — not investment advice.